Part, Chapter, Paragraph
1 I, 2. 10. 2 | animal health, veterinary drugs, pesticides and plant health.~ ~
2 I, 2. 10. 2 | bioseparations and as vectors of drugs, bioactive molecules and
3 I, 2. 10. 4 | for each and every pack of drugs or medical device, which
4 I, 2. 10. 4 | unique identification for drugs or medical device, where
5 I, 2. 10. 4 | worst case, two packs of drugs with the same serial number
6 II, 4. 1 | consumption of alcohol, drugs and tobacco and reducing
7 II, 5. 1. 1 | patients exposed to nephrotoxic drugs are at higher risk for CKD.
8 II, 5. 1. 2 | pharmaceutical industry and drugs, but these diagnostic and
9 II, 5. 2. 3 | care setting: thrombolytic drugs, PTCA and CABG. Given the
10 II, 5. 2. 5 | pharmacological treatment with drugs must be considered.~For
11 II, 5. 2. 6 | various hypocholesterolemic drugs have definitively shown,
12 II, 5. 2. 6 | and the availability of drugs able to inhibit cholesterol
13 II, 5. 2. 6 | association of two or more drugs is often necessary to achieve
14 II, 5. 3. 2 | patient access to cancer drugs by Karolinska Institute
15 II, 5. 3. 2 | availability of new cancer drugs. See: http://annonc.oxfordjournals.
16 II, 5. 3. 7 | increasing cost of anticancer drugs and devices is an important
17 II, 5. 3. 7 | countries. The use of anticancer drugs should be restricted to
18 II, 5. 3. 7 | patient access to cancer drugs” (Jonsson et al, 2007) highlights
19 II, 5. 3. 7 | of new innovative cancer drugs through the competent authorities.~·
20 II, 5. 3. 7 | for new innovative cancer drugs is available for the health
21 II, 5. 3. 7 | to develop new innovative drugs, it comes to the health
22 II, 5. 3. 7 | system to integrate these drugs into therapy programs. It
23 II, 5. 3. 7 | toxicity for most of the drugs.~· With respect to pricing,
24 II, 5. 3. 7 | purchasing power. Secondly, new drugs are often launched in a
25 II, 5. 3. 7 | phase. For example, many new drugs have been introduced in
26 II, 5. 5.Int | mood altering psychotropic drugs. Men are more likely to
27 II, 5. 5.Int | addressed the misuse of drugs and the harm caused by alcohol.
28 II, 5. 5. 3 | schizophrenia since these drugs are applied also to treat
29 II, 5. 5. 3 | there is a need to identify drugs that may have favourable
30 II, 5. 5. 3 | development of innovative drugs.~The social situation –
31 II, 5. 5. 3 | including the development of new drugs, since prevention will hopefully
32 II, 5. 5. 3 | generation antipsychotic drugs recommended by international
33 II, 5. 5. 3 | second-generation antipsychotic drugs (Kahn et al, 2008). Non-compliance
34 II, 5. 5. 3 | three essential psychotropic drugs – an antidepressant, an
35 II, 5. 5. 3 | treatment, psychotropic drugs and mental health workers.
36 II, 5. 5. 3 | Effectiveness of antipsychotic drugs in first-episode schizophrenia
37 II, 5. 5. 3 | receiving antiepileptic drugs (AEDs)(Commission, 1993).
38 II, 5. 5. 3 | two or more antiepileptic drugs and one or more seizures
39 II, 5. 5. 3 | months Ban in people taking drugs contraindicated~ with driving~
40 II, 5. 5. 3 | Norway I 12 months Drugs stolen or last seizure in
41 II, 5. 5. 3 | driving;~AED = Antiepileptic drugs; EEG = Electroencephalogram.~ ~ ~ ~
42 II, 5. 5. 3 | cure for MS, but there are drugs able to slow down the underlying
43 II, 5. 5. 3 | administration of these drugs (injections and up to every
44 II, 5. 5. 3 | potential side effects of these drugs is critical for the patients
45 II, 5. 5. 3 | ensure compliance. Other drugs are used, such as azathioprine,
46 II, 5. 5. 3 | cyclophosphamide. A number of drugs are being tested some of
47 II, 5. 5. 3 | of Parkinson’s disease. Drugs Aging 23(9):693-721.~Eichhorn
48 II, 5. 6.Acr | anti-inflammatory analgesics drugs~OA~Osteoarthritis~RA~Rheumatoid
49 II, 5. 6. 3 | with new disease modifying drugs, better pain management
50 II, 5. 7. 4 | patients exposed to nephrotoxic drugs are at higher risk for CKD.~ ~
51 II, 5. 7. 5 | example when nephrotoxic drugs should be used for the treatment
52 II, 5. 8. 3 | ambulatory care, 2.7 for drugs, 2.9 for inpatient care
53 II, 5. 9. 3 | providers. Antiallergic drugs should be evaluated in terms
54 II, 5. 9. 3 | ambulatory care (€ 3.8 billion), drugs (€ 3.6 billion) and inpatient
55 II, 5. 9. 5 | targets.~New anti-allergic drugs should be evaluated in terms
56 II, 5. 15.Acr | Rare Disorders~OD~Orphan Drugs~RD~Rare Diseases~ ~
57 II, 5. 15. 3 | available data concerns Orphan Drugs (OD), drugs developed for
58 II, 5. 15. 3 | concerns Orphan Drugs (OD), drugs developed for a rare condition.
59 II, 5. 15. 3 | study on the price of orphan drugs (OD). The study, conducted
60 II, 5. 15. 3 | looks at the price of orphan drugs authorised in the EU and
61 II, 5. 15. 3 | on the access to orphan drugs in Europe (dates of national
62 II, 5. 15. 3 | not respected, and orphan drugs are made available in a
63 II, 5. 15. 3 | worse than those for other drugs, although they are intended
64 II, 5. 15. 4 | in discussions on orphan drugs.~ ~DG Public Health established
65 II, 5. 15. 6 | 2004): Study on Orphan Drugs. Published 16/11/04. Available
66 II, 5. 15. 6 | approach to reviewing new drugs condemning the victims of
67 II, 5. 15. 6 | challenges posed by orphan drugs. Int J Technol Assess Health
68 II, 5. 15. 6 | 2006): Adopting orphan drugs -- two dozen years of treating
69 II, 5. 15. 6 | budgets for expensive orphan drugs: Gaucher disease in Israel
70 II, 5. 15. 6 | Tsuchiya A (2005): Orphan drugs and the NHS: should we value
71 II, 5. 15. 6 | rare diseases and orphan drugs. Available at: htt et~Van
72 II, 5. 15. 6 | rare diseases and orphan drugs. J Intern Med. 2006; 260(
73 II, 6. 4. 3 | vaccines and anti-viral drugs.~ ~The Commission also supports
74 II, 6. 4. 3 | both vaccines and antiviral drugs.~ ~
75 II, 9 | potential dangers of therapeutic drugs taken during early pregnancy.
76 II, 9 | early pregnancy. A number of drugs are now known to be teratogenic (
77 II, 9 | necessary (such as antiepileptic drugs) but a careful selection
78 II, 9 | postmarketing surveillance of drugs taken during pregnancy is
79 II, 9 | possible that there are more drugs currently on the market
80 II, 9 | research.~ ~Recreational drugs such as cocaine and solvent
81 II, 9 | data). Looking at other drugs also brings Estonia, Germany,
82 II, 9. 1. 2 | potential dangers of therapeutic drugs taken during early pregnancy.
83 II, 9. 1. 2 | early pregnancy. A number of drugs are now known to be teratogenic (
84 II, 9. 1. 2 | necessary (such as antiepileptic drugs) but a careful selection
85 II, 9. 1. 2 | postmarketing surveillance of drugs taken during pregnancy is
86 II, 9. 1. 2 | possible that there are more drugs currently on the market
87 II, 9. 1. 2 | research.~ ~Recreational drugs such as cocaine and solvent
88 II, 9. 1. 2 | as alcohol, recreational drugs, smoking and obesity, are
89 II, 9. 1. 2 | systematic follow-up of medicinal drugs and assisted reproduction
90 II, 9. 1. 2 | Scialli A, Peters P (2001): Drugs during pregnancy and lactation:
91 II, 9. 1. 2 | handbook of prescription drugs and comparative risk assessment.
92 II, 9. 2. 2 | Project on Alcohol and Other Drugs (ESPAD): This is an important (
93 II, 9. 2. 2 | alcohol, tobacco, and other drugs. Its web site provides considerable
94 II, 9. 2. 4 | data). Looking at other drugs also brings Estonia, Germany,
95 II, 9. 3. 1 | mood altering psychotropic drugs. Men are more likely to
96 II, 9. 3. 1 | there are new bone-specific drugs and broad-spectrum drugs
97 II, 9. 3. 1 | drugs and broad-spectrum drugs that combat osteoporosis
98 II, 9. 3. 1 | dysfunctional conditions, or drugs. Dysfunctional uterine bleeding
99 II, 9. 3. 1 | prescription and recreational drugs implicated. Moreover, it
100 II, 9. 3. 1 | and previous diseases and drugs taken should then be considered.
101 II, 9. 3. 3 | as alcohol consumption, drugs and substance abuse and
102 II, 9. 4. 3 | prescription of psychotropic drugs and safe housing (European
103 II, 9. 5. 2 | framework (Cancer, HIV/AIDS, Drugs, health promotion, Health
104 II, 9. 5. 3 | mood altering psychotropic drugs. The disability associated
105 III, 10. 1. 3 | Chermack ST (1993): Alcohol, drugs and human physical aggression.
106 III, 10. 2. 1 | alcohol, homicides, illegal drugs, suicides and fires combined.~ ~
107 III, 10. 2. 1 | ambulatory care, prescription drugs, home health care and nursing
108 III, 10. 2. 1 | pharmacotherapy includes several drugs from different categories.
109 III, 10. 2. 1 | They are both prescription drugs approved by national authorities
110 III, 10. 2. 1 | Driving under the influence of drugs, alcohol and medicine~ECAS~
111 III, 10. 2. 1 | Project on Alcohol and Other Drugs~FAO~Food and Agriculture
112 III, 10. 2. 1 | Project on Alcohol and Other Drugs (ESPAD; part-financed by
113 III, 10. 2. 1 | Project on Alcohol and Other Drugs (ESPAD) found that the average
114 III, 10. 2. 1 | childhood abuse and use of other drugs in addition to alcohol are
115 III, 10. 2. 1 | Driving under influence of drugs, alcohol and medicine~http ~ ~
116 III, 10. 2. 1 | Nordic Studies on Alcohol and Drugs 20 25-40.~ ~Kristenson H,
117 III, 10. 2. 1 | 10.2.1.3. Drugs and substance misuse1~ ~
118 III, 10. 2. 1(1)| Non-medical use of drugs that have been classified
119 III, 10. 2. 1(1)| Single Convention on Narcotic Drugs (as amended in 1972) and
120 III, 10. 2. 1(1)| as amended in 1972) and drugs placed under international
121 III, 10. 2. 1 | European Monitoring Centre for Drugs and Drug Addiction~ESPAD~
122 III, 10. 2. 1 | Project on Alcohol and Other Drugs~HBSC~Health Behaviour among
123 III, 10. 2. 1 | European Information Network on Drugs and Drug Addiction~TDI~Treatment
124 III, 10. 2. 1 | other - often synthetic - drugs are also sometimes used.
125 III, 10. 2. 1 | cocaine and other stimulant drugs by socially integrated individuals
126 III, 10. 2. 1 | of administration of the drugs are, depending on the physical
127 III, 10. 2. 1 | long term use of illicit drugs. The social situation of
128 III, 10. 2. 1 | European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
129 III, 10. 2. 1 | the most frequently used drugs among the general population
130 III, 10. 2. 1 | numbers of users of different drugs in the European Union and
131 III, 10. 2. 1 | last year use of different drugs shows that more than 10%
132 III, 10. 2. 1 | drug use~ ~Use of illicit drugs can begin as early as in
133 III, 10. 2. 1 | prevalence of the use of other drugs has also occurred.~ ~Figure
134 III, 10. 2. 1 | problems related to the use of drugs (Table 10.2.1.3.2).~ ~Table
135 III, 10. 2. 1 | although they may inject other drugs as well. Some countries
136 III, 10. 2. 1 | consumption of one or more drugs and that occur, generally,
137 III, 10. 2. 1 | heroin clients among all new drugs clients seeking treatment
138 III, 10. 2. 1 | use.~ ~Historically, the drugs debate has been polarised
139 III, 10. 2. 1 | consumption of stimulant drugs such as cocaine by well
140 III, 10. 2. 1 | the misuse of prescribed drugs (opioids, benzodiazepines
141 III, 10. 2. 1 | source of both information on drugs and as a means for promoting
142 III, 10. 2. 1 | alternatives to prohibited drugs on the other. This problem
143 III, 10. 2. 1 | European Monitoring Centre for Drugs and Drug Addiction (EMCDDA),
144 III, 10. 2. 1 | European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
145 III, 10. 2. 1 | Project on Alcohol and Other Drugs (ESPAD) (2003): Psychoactive
146 III, 10. 2. 2 | well as the availability of drugs able to inhibit cholesterol
147 III, 10. 2. 4 | Rare Diseases and Orphan Drugs~PHG~Public Health Genomics~
148 III, 10. 2. 4 | variants on the metabolism of drugs and the development of drug
149 III, 10. 2. 4 | negative side-effects of drugs as physicians and policy
150 III, 10. 2. 4 | look at the metabolism of drugs and the impact of the CYP
151 III, 10. 3. 2 | electronics, anti-cancer drugs (Pt), catalysts in various
152 III, 10. 3. 4 | floods and no shortage of drugs or vaccines was reported.
153 III, 10. 5. 3 | for addictions (alcohol, drugs).~ ~Impact of work on mortality,
154 III, 10. 6. 2 | society free from illicit drugs and doping, and a reduction
155 IV, 11. 1. 5 | Preventable adverse reactions to drugs are claimed to be the single
156 IV, 11. 1. 5 | administration of intravenous drugs (Taxis and Barber, 2003).
157 IV, 11. 3. 2 | prescription and over-the-counter drugs, with the latter that normally
158 IV, 11. 3. 2 | average or median price of drugs with similar pharmacotherapeutic
159 IV, 11. 3. 2 | for limiting spending on drugs is currently exclusively
160 IV, 11. 3. 2 | to reimburse the cost of drugs to the insurance beneficiaries
161 IV, 11. 3. 2 | of less expensive generic drugs for brand name drugs once
162 IV, 11. 3. 2 | generic drugs for brand name drugs once the pharmaceutical
163 IV, 11. 3. 2 | Policies to promote generic drugs are prevalent in Europe,
164 IV, 11. 3. 2 | 11.4. Relative prices of drugs across EU25 based on price
165 IV, 11. 5. 6 | specific immunosuppressive drugs, and the experience acquired
166 IV, 11. 6. 2 | sharing for prescription drugs leads to worse health outcomes,
167 IV, 11. 6. 2 | al, 2003). Prescription drugs may have cost sharing in
168 IV, 11. 6. 2 | full cost of prescription drugs up to an out-of-pocket maximum.
169 IV, 11. 6. 5 | sharing for prescription drugs: implications for equity
170 IV, 12. 2 | pharmacological treatment with drugs must be considered.~ ~Finland
171 IV, 12. 2 | pharmacotherapy includes several drugs from different categories.
172 IV, 12. 2 | They are both prescription drugs approved by national authorities
173 IV, 12. 2 | Driving under influence of drugs, alcohol and medicine~http
174 IV, 12. 4 | and services.~JLS~Illegal Drugs; Immigration policy and
175 IV, 12. 4 | European Monitoring Centre for Drugs and Drug Addiction (Lisbon,
176 IV, 12. 4 | European level concerning drugs and drug addiction and their
177 IV, 12. 4 | management of migration flows~Drugs Prevention and Information
178 IV, 12. 5 | tobacco, alcohol, illegal drugs and pharmaceuticals used
179 IV, 12. 10 | Physical activity~High ~Regional~ Yes~Drugs and substance abuse~High ~
180 IV, 12. 10 | AGAINST OBESITY~http df~Drugs and substance abuse~ high~ ~
181 IV, 12. 10 | ability to say “no’” to drugs including alcohol~Project “
182 IV, 12. 10 | Sportstättenbauförderung, see www. ~ ~Drugs and substance abuse~High
183 IV, 12. 10 | framework in reference to drugs and substance abuse consists
184 IV, 12. 10 | concerning different sorts of drugs (e. g. “Quit the shit”-program
185 IV, 12. 10 | the consumption of illegal drugs (Project supported by Federal
186 IV, 12. 10 | of (ex-)users of illegal drugs in co-operation with German
187 IV, 12. 10 | further information see “Drugs and Addiction Report” of
188 IV, 12. 10 | Federal Institute for Drugs and Medical Devices (Bundesinstitut
189 IV, 12. 10 | animal feed and veterinary drugs, tobacco products, plant
190 IV, 12. 10 | animal feed and veterinary drugs, tobacco products, plant
191 IV, 12. 10 | see Federal Institute for Drugs and Medical Devices/Bundesinstituts
192 IV, 12. 10 | Guidelines are being published.~Drugs and substance abuse~High~
193 IV, 12. 10 | abuse~High~ The Misuse of Drugs Act 1977 and the Regulations
194 IV, 12. 10 | range of named narcotic drugs and psychotropic substances
195 IV, 12. 10 | by the~Local and Regional Drugs Task Forces.~Local and Regional
196 IV, 12. 10 | Forces.~Local and Regional Drugs Task Forces~which are partnerships
197 IV, 12. 10 | High~In line with the EU Drugs Action Plan~developments
198 IV, 12. 10 | National Advisory Committee on Drugs~(NACD) Report An Overview
199 IV, 12. 10 | cocaine and prescribed~drugs). The HSE is up-skilling
200 IV, 12. 10 | of the working~group on Drugs Rehabilitation was~published
201 IV, 12. 10 | National Advisory Committee~on Drugs in September 2007 published~
202 IV, 12. 10 | Main campaign programs~Drugs and substance abuse~ High~ ~ ~
203 IV, 12. 10 | health nutrition programs~Drugs and substance abuse~ high~
204 IV, 12. 10 | places for reducing risks for drugs users~2007: inside prevention
205 IV, 12. 10 | and awareness training for drugs users~ Permanent campaign
206 IV, 12. 10 | stiliVita/stiliVita.jsp)~Drugs and substance abuse~ High~
207 IV, 12. 10 | Pharmaceuticals~ ~National Drugs Agency (Agenzia Italiana
208 IV, 12. 10 | harmonisation~ ~National Drugs Agency (Agenzia Italiana
209 IV, 12. 10 | Reducing harm from alcohol, drugs and tobacco” in national
210 IV, 12. 10 | Reducing harm from alcohol, drugs and tobacco” in national
211 IV, 12. 10 | Public Health Strategy~ ~Drugs and substance abuse~intermediate~
212 IV, 12. 10 | Reducing harm from alcohol, drugs and tobacco” in national
213 IV, 12. 10 | Health Determinants Programme~Drugs and substance abuse~ High~
214 IV, 12. 10 | health nutrition programs~Drugs and substance abuse~ High~
215 IV, 12. 10 | use of alcohol, illicit drugs and smoking. As part of
216 IV, 12. 10 | Agriculture policy~Use of illicit drugs~Self-reported use of illicit
217 IV, 12. 10 | Self-reported use of illicit drugs~ ~Mortality~Domain of objective
218 IV, 12. 10 | society free from illicit drugs and doping, and a reduction
219 IV, 12. 10 | level~ Local programmes~Drugs and substance abuse~ High~
220 IV, 13. 2. 4 | refraining from illicit drugs and unsafe sex would lessen
221 Key, Ap5. 0. 0 | drug-induced~drug-resistant~drugs~duchenne~dust~dust-mite~
